ethinyl estradiol-norgestrel combination has been researched along with Hypertension in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, IK; Olatunji, LA; Seok, YM; Usman, TO | 1 |
| Igunnu, A; Kang, SH; Kim, IK; Olatunji, LA; Seok, YM | 1 |
| Olatunji, LA; Soladoye, AO | 1 |
| Dewsbury, JA; Kirkman, RJ; Loudon, NB | 1 |
| Dubnitskaia, LV; Kuramshina, AKh; Trutko, NS | 1 |
| Dubnitskaia, LV; Korsakov, SG; Manuilova, IA | 1 |
1 trial(s) available for ethinyl estradiol-norgestrel combination and Hypertension
| Article | Year |
|---|---|
A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hypertension; Menstrual Cycle; Multicenter Studies as Topic; Norgestrel; Norpregnenes; Patient Dropouts; Random Allocation; United Kingdom | 1990 |
5 other study(ies) available for ethinyl estradiol-norgestrel combination and Hypertension
| Article | Year |
|---|---|
Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder.
Topics: Aldosterone; Animals; Ataxia Telangiectasia Mutated Proteins; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dyslipidemias; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Intolerance; Heart; Hyperinsulinism; Hypertension; Insulin Resistance; Metabolic Syndrome; Myocardium; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Random Allocation; Rats, Sprague-Dawley; Renin-Angiotensin System; Up-Regulation | 2017 |
Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression.
Topics: Animals; Blood Pressure; Contraceptives, Oral, Combined; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Ethinyl Estradiol-Norgestrel Combination; Female; Hypertension; Inflammation Mediators; Kidney Cortex; Nitric Oxide; Peptidyl-Dipeptidase A; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Up-Regulation; Uric Acid; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2016 |
Effects of chronic treatment with cyclooxygenase inhibitor, indomethacin on oral contraceptive-induced high blood pressure in female rats.
Topics: Animals; Blood Pressure; Cardiomegaly; Contraceptives, Oral, Combined; Cyclooxygenase Inhibitors; Ethinyl Estradiol-Norgestrel Combination; Female; Hypertension; Indomethacin; Organ Size; Pressoreceptors; Rats; Rats, Sprague-Dawley | 2010 |
[Indicators of arterial blood pressure during hormonal contraception].
Topics: Adult; Blood Pressure; Chlormadinone Acetate; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hypertension; Norethindrone; Norgestrel; Risk; Time Factors | 1985 |
[Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Chlormadinone Acetate; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease Susceptibility; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hypertension; Middle Aged; Norethindrone; Norgestrel; Risk Factors | 1989 |